Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00427) | |||||
---|---|---|---|---|---|
Name |
Metyrosine
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
METYROSINE; 672-87-7; alpha-Methyl-L-tyrosine; Metirosine; Demser; (S)-alpha-Methyltyrosine; (S)-2-Amino-3-(4-hydroxyphenyl)-2-methylpropanoic acid; Methyltyrosine; alpha-Methyltyrosine; L-alpha-Methyl-p-tyrosine; Metirosinum; Metirosina; L-alpha-Methyltyrosine; Alpha-Methyl-L-P-Tyrosine; (2S)-2-amino-3-(4-hydroxyphenyl)-2-methylpropanoic acid; (-)-alpha-Methyl-L-tyrosine; UNII-DOQ0J0TPF7; MK-781; alpha-Methyl-para-tyrosine; DOQ0J0TPF7; ALPHA-METHYL-L-TYR; CHEBI:6912; MFCD00064201; NCGC00094144-03; DSSTox_CID_3315; DSSTox_RID_76972; DSSTox_GSID_23315; L-588357-0; alpha-MPT; CAS-672-87-7; (R)-alpha-Methyltyrosine; alpha-methyl-paratyrosine; Metyrosine [USAN:USP]; Metirosinum [INN-Latin]; MK 781; Metirosina [INN-Spanish]; L-2-ME-TYR-OH; alpha-Me-Tyr-OH; Metirosine [INN]; Metyrosine (USP); EINECS 211-599-5; Demser (TN); a-methyl-L-p-tyrosine; L- -methyl-Tyrosine; L-AMPT; Metirosine (JAN/INN); Spectrum3_001846; H-(ME)TYR-OH; A-METHYL-L-TYROSINE; (S)-2-(4-Hydroxybenzyl)-2-aminopropanoic Acid; Lopac0_000811; SCHEMBL50398; BSPBio_003232; ZINC693; SPECTRUM2300312; GTPL6956; L 588357-0; CHEMBL1200862; DTXSID6023315; KBio3_002732; (-)-(S)-2-Amino-3-(4-hydroxyphenyl)-2-methylpropionsaeure; HMS3262D03; L-Tyrosine, alpha-methyl-, (-)-; Tox21_111253; Tox21_500811; AKOS016844271; Tox21_111253_1; AB02561; AM83582; CCG-204895; CS-W015723; DB00765; HY-W015007; LP00811; MCULE-5340647798; SDCCGSBI-0050788.P002; NCGC00015701-06; NCGC00094144-01; NCGC00094144-04; NCGC00094144-05; NCGC00094144-06; NCGC00094144-07; NCGC00094144-11; NCGC00261496-01; AC-32982; alpha-Methyl-L-tyrosine, >=98% (TLC); AS-47139; L-2-Methyl-3-(4-hydroxy-phenyl)alanine; EU-0100811; C07921; D00762; L-2-METHYL-3-(4-HYDROXYPHENYL)ALANINE; M 8131; 672M877; A835693; Q6824116; Z1617901128; UNII-X88TTO174Z component NHTGHBARYWONDQ-JTQLQIEISA-N; (2S)-2-azanyl-3-(4-hydroxyphenyl)-2-methyl-propanoic acid; Metyrosine, United States Pharmacopeia (USP) Reference Standard; (S)-a-Methyl-4-hydroxy phenylalanine, (S)-a-Methyltyrosine (>98%, >98%ee)
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Pheochromocytoma | ICD-11: 5A75 | [1] | ||
PubChem CID | |||||
Formula |
C10H13NO3
|
||||
Canonical SMILES |
C[C@](CC1=CC=C(C=C1)O)(C(=O)O)N
|
||||
InChI |
1S/C10H13NO3/c1-10(11,9(13)14)6-7-2-4-8(12)5-3-7/h2-5,12H,6,11H2,1H3,(H,13,14)/t10-/m0/s1
|
||||
InChIKey |
NHTGHBARYWONDQ-JTQLQIEISA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=441350"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 195.21 | Topological Polar Surface Area | 83.6 | |
XlogP | -1.6 | Complexity | 211 | ||
Heavy Atom Count | 14 | Rotatable Bond Count | 3 | ||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 4 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Metyrosine 250 mg capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Silicon dioxide; Gelatin; Hydroxypropyl cellulose (type h)
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Aton Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.